AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2015

Oct 9, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2015-10-07

Reporting Person: Higgons John Duncan (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-07	Common stock	G	70000	$0.00	Disposed	81835	Direct

Footnotes

F1: Reflects a gift of shares from the reporting person to charity.